CSIMarket
 


Insulet Corporation  (NASDAQ: PODD)
Other Ticker:  
 


Insulet's Operating Profit Margin, Return on Sales by quarter

Trends, Rankings, Statistics





PODD Operating Profit Margin, Return on Sales (Sep 30 2025)
Q3
(Jun 30 2025)
Q2
(Mar 31 2025)
Q1
(Dec 31 2024)
Q4
(Sep 30 2024)
Q3
Y / Y Revenue Change 29.86 % 32.88 % 28.82 % 17.2 % 25.7 %
Seq. Revenue Change 8.81 % 14.08 % -4.77 % 9.85 % 11.34 %
Revenue In Millions $706.30 $649.10 $569.00 $597.50 $543.90
Operating Profit Margin, Return on Sales 16.66 % 18.66 % 15.61 % 18.29 % 16.2 %
Operating Profit Margin, Return on Sales Total Ranking # 1240 # 1074 # 1294 # 1237 # 1276
Operating Income In Millions $117.70 $121.10 $88.80 $109.30 $88.10
Y / Y Operating Income Change 33.6 % 121.79 % 56.06 % 2.73 % 60.77 %
Seq. Operating Income Change -2.81 % 36.37 % -18.76 % 24.06 % 61.36 %


Commenting Third Quarter 2025 Operating Profit Margin, Return on Sales
Company's Operating Profit Margin, Return on Sales sequentially deteriorated to 16.66 % due to increase in Operating Costs and despite Revenue increase of 8.81 % to $706 millions.
Company's Operating Profit Margin, Return on Sales in III. Quarter, was above company average.


Observing third quarter 2025 results within Medical Equipment & Supplies industry 28 other companies have achieved higher Operating Profit Margin, Return on Sales. While Operating Profit Margin, Return on Sales overall ranking has deteriorated relative to the three months before, from 1074 to 1240.
Explain Operating Margin
PODD's Operating Profit Margin, Return on Sales third quarter 2025 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 29
Healthcare Sector # 103
Overall # 1240

Operating Profit Margin, Return on Sales Statistics
High Average Low
20.87 % 9.62 % 0.3 %
(Dec 31 2023)   (Dec 31 2013)




Other Operating Profit Margin, Return on Sales Profitability Ratios
PODD's Cumulative Operating Profit Margin, Return on Sales
Medical Equipment & Supplies Industry Operating Profit Margin, Return on Sales Trends and Statistics
Healthcare Sector Operating Profit Margin, Return on Sales Statistics
Operating Profit Margin, Return on Sales Profitability Trends for overall market
PODD's Operating Profit Margin, Return on Sales Profitability versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Operating Profit Margin, Return on Sales
Lowest Ranking Operating Profit Margin, Return on Sales
Operating Profit Margin, Return on Sales Profit Margin for PODD's Competitors
Operating Profit Margin, Return on Sales Profit Margin for Insulet's Suppliers
Operating Profit Margin, Return on Sales Profit Margin for PODD's Customers

You may also want to know
PODD's Annual Growth Rates PODD's Profitability Ratios PODD's Asset Turnover Ratio PODD's Dividend Growth
PODD's Roe PODD's Valuation Ratios PODD's Financial Strength Ratios PODD's Operating Income Growth
PODD's Roa PODD's Inventory Turnover Ratio PODD's Growth Rates PODD's Dividend Comparisons


Companies with similar Operating Profit Margin, Return on Sales in the quarter ending Sep 30 2025, within Medical Equipment & Supplies Industry Operating Profit Margin, Return on SalesSep 30 2025 MRQ Operating IncomeSep 30 2025 MRQ Revenue
Resmed Inc   33.65 %$ 446.537  Millions$ 1,326.820  Millions
Soleno Therapeutics Inc  33.48 %$ 22.105  Millions$ 66.018  Millions
Lemaitre Vascular Inc   33.32 %$ 20.312  Millions$ 60.955  Millions
Iradimed Corporation  32.23 %$ 6.834  Millions$ 21.202  Millions
Intuitive Surgical Inc   30.33 %$ 759.700  Millions$ 2,504.400  Millions
Utah Medical Products Inc  27.19 %$ 2.611  Millions$ 9.604  Millions
Masimo Corp  22.56 %$ 83.600  Millions$ 370.600  Millions
3m Company  22.20 %$ 1,447.000  Millions$ 6,517.000  Millions
Carlisle Companies Incorporated  21.82 %$ 293.900  Millions$ 1,346.900  Millions
Embecta Corp   21.28 %$ 56.500  Millions$ 265.500  Millions
West Pharmaceutical Services Inc   20.84 %$ 167.600  Millions$ 804.300  Millions
Boston Scientific Corporation  20.69 %$ 1,048.000  Millions$ 5,065.000  Millions
Msa Safety Inc  20.17 %$ 94.310  Millions$ 467.616  Millions
Dexcom Inc   20.07 %$ 242.500  Millions$ 1,208.400  Millions
Edwards Lifesciences Corporation  19.78 %$ 307.100  Millions$ 1,552.900  Millions
Mimedx Group Inc   19.64 %$ 22.190  Millions$ 113.006  Millions
Staar Surgical Co  19.52 %$ 18.490  Millions$ 94.732  Millions
Medtronic Plc  18.81 %$ 1,686.000  Millions$ 8,961.000  Millions
Stryker Corp  18.74 %$ 1,135.000  Millions$ 6,057.000  Millions
Steris Plc  18.20 %$ 265.800  Millions$ 1,460.300  Millions
Haemonetics Corporation  17.90 %$ 58.491  Millions$ 326.744  Millions
Globus Medical Inc   17.86 %$ 137.363  Millions$ 769.048  Millions
Zimmer Biomet Holdings Inc   17.55 %$ 351.300  Millions$ 2,001.400  Millions
Pro dex Inc   16.78 %$ 3.109  Millions$ 18.530  Millions
Insulet Corporation  16.66 %$ 117.700  Millions$ 706.300  Millions
Electromed Inc   16.48 %$ 2.670  Millions$ 16.197  Millions
Medinotec Inc   16.33 %$ 0.529  Millions$ 3.236  Millions
Transmedics Group Inc   16.20 %$ 23.300  Millions$ 143.823  Millions
Ufp Technologies Inc   15.21 %$ 23.379  Millions$ 153.747  Millions
Livanova Plc  15.14 %$ 54.012  Millions$ 356.855  Millions




Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2025 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.